Cost-effectiveness of second-line agents added to metformin for cardiovascular risk reduction
碩士 === 國立臺灣大學 === 健康政策與管理研究所 === 106 === Objective: To evaluate the cost-effectiveness of adding relevant second-line agents to metformin for cardiovascular disease reduction in a type 2 diabetes population using post-marketing observational data. Methods: First, a retrospective national propensity...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/7b9x52 |